Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Exciting gene therapy study helps patients with hemophilia B.
Arthur Nienhuis, M.D., of St. Jude Children’s Research Hospital, is the recipient of the 2009 Mentor Award from the American Society of Hematology (ASH).
Former St. Jude Director Arthur W. Nienhuis, M.D., and George Simon, chair of the St. Jude Board of Governors, recently announced that William E. Evans, Pharm.D., assumed the position of St. Jude Director and CEO. Nov. 1, 2004.
Researchers at St. Jude Children's Research Hospital have overcome two major technical obstacles that currently limit the success of gene therapy for human red blood cell diseases such as beta-thalassemia and sickle cell disease.
Arthur Nienhuis, M.D., and William Evans, Pharm.D., of St. Jude Children's Research Hospital have been elected to the Institute of Medicine, a prestigious branch of the National Academy of Sciences.